Amedeo's Top 20

Amedeo Smart

Independent Medical Education


08 August 2022

Multidisciplinary Journal Club

  1. Sun L, Guo D, Jia Y, Shi M, et al.
    Association Between Human Blood Metabolome and the Risk of Alzheimer's Disease.
    Ann Neurol 2022.

  1. Krijbolder DI, Verstappen M, van Dijk BT, Dakkak YJ, et al.
    Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proo
    Lancet 2022;400:283-294.

  2. Piller C.
    Blots on a field?
    Science 2022;377:358-363.

  3. Reddy YNV, Borlaug BA, Gersh BJ.
    Management of Atrial Fibrillation Across the Spectrum of Heart Failure With Preserved and Reduced Ejection Fraction.
    Circulation 2022;146:339-357.

  4. Mielke MM, Dage JL, Frank RD, Algeciras-Schimnich A, et al.
    Performance of plasma phosphorylated tau 181 and 217 in the community.
    Nat Med 2022;28:1398-1405.

  1. Bargon CA, Young-Afat DA, Ikinci M, Braakenburg A, et al.
    Breast cancer recurrence after immediate and delayed postmastectomy breast reconstruction-A systematic review and meta-analysis.
    Cancer 2022.

  2. Kim NR, Lee AJ, Yang EJ, So KA, et al.
    Minimally invasive surgery versus open surgery in high-risk histologic endometrial cancer patients: A meta-analysis.
    Gynecol Oncol 2022.

  3. Koppe L, Soulage CO.
    The impact of dietary nutrient intake on gut microbiota in the progression and complications of chronic kidney disease.
    Kidney Int 2022.

  4. Devan SP, Jiang X, Luo G, Xie J, et al.
    Selective cell size MRI differentiates brain tumors from radiation necrosis.
    Cancer Res 2022.

  5. Campbell D, Butler E, Barber PA.
    End the confusion: general anaesthesia improves patient outcomes in endovascular thrombectomy.
    Br J Anaesth 2022.

  1. Shahim P, Zetterberg H, Simren J, Ashton NJ, et al.
    Association of Plasma Biomarker Levels With Their CSF Concentration and the Number and Severity of Concussions in Professional Athletes.
    Neurology 2022;99:e347-e354.

  2. Garrido-Torres N, Ruiz-Veguilla M, Alameda L, Canal-Rivero M, et al.
    Prevalence of metabolic syndrome and related factors in a large sample of antipsychotic naive patients with first-episode psychosis: Baseline results from the PAFIP cohort.
    Schizophr Res 2022;246:277-285.

  3. Labib MA, Rumalla K, Karahalios K, Srinivasan VM, et al.
    Cost Comparison of Microsurgery vs Endovascular Treatment for Ruptured Intracranial Aneurysms: A Propensity-Adjusted Analysis.
    Neurosurgery 2022.

  4. Hawkes MA, Anderson CS, Rabinstein AA.
    Blood Pressure Variability After Cerebrovascular Events: A Possible New Therapeutic Target: A Narrative Review.
    Neurology 2022;99:150-160.

  5. Luckhurst CM, El Hechi M, Maurer LR, Yamada K, et al.
    Treatment and Prevention of Intraabdominal Bleeding in Necrotizing Pancreatitis Patients Treated With a Step-Up Approach.
    Pancreas 2022.

  1. Nasioudis D, Mastroyannis SA, Ko EM, Haggerty AF, et al.
    Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival; an analysis of the National Cancer Database.
    Gynecol Oncol 2022.

  2. Lof P, van de Vrie R, Korse CM, van Gent MDJM, et al.
    Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital?
    Gynecol Oncol 2022.

  3. Jackson JL, Kuriyama A, Bernstein J, Demchuk C, et al.
    Depression in primary care, 2010-2018.
    Am J Med 2022.

  4. Saltiki K, Simeakis G, Karapanou O, Alevizaki M, et al.
    MANAGEMENT OF ENDOCRINE DISEASE: Medullary thyroid cancer: from molecular biology and therapeutic pitfalls to future targeted treatment perspectives.
    Eur J Endocrinol 2022;187:R53-R63.

  5. Desai R, Park H, Brown J, Mohandas R, et al.
    Comparative Safety and Effectiveness of Aldosterone Antagonists Versus Beta-Blockers as Fourth Agents in Patients With Apparent Resistant Hypertension.
    Hypertension 2022.


more..


Privacy Policy